5PSQ-102 Hazardous drug colour marks the difference

BACKGROUND: Hazardous drugs (MPs) are defined as the drugs that cause carcinogenicity, teratogenicity, reproductive toxicity, low-dose organ toxicity, genotoxicity, and new drugs with structure profiles and toxicity similar to existing drugs that were determined to be hazardous according to the abov...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Hosp Pharm
Main Authors: Machín, A Ferrer, Gil, JA Leon, Cabrera, M Vera, Santana, E Ramos, Dávila, MA Navarro, Rojas, S Hernández, Delgado, A Montero, García, I Plasencia, Romero, K Viñas, Clemente, C Fraile, Alonso, FJ Merino
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2018
Assuntos:
Section 5: Patient safety and quality assurance
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535399/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.455
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados